The term triple-negative breast cancer (TNBC) describes a subtype of breast cancer in which expression of the three primary breast tumor markers, including estrogen receptor (ER), progesterone receptor (PR), and HER2 protein, is absent. Here, ERBB2 is linked to breast cancer.